Loading…
Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers
Objective To examine the clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan. Method We examined the attributes, ICD‐10 subcategory, and comorbid mental disorders of patients who mainly abuse OTC products and compared the clinical characteristics of singl...
Saved in:
Published in: | Neuropsychopharmacology reports 2024-03, Vol.44 (1), p.176-186 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c5415-8d4fbefdcbb47eb2e3b05f225aee2dc19803dcc48c0bab83a0feef22ce8310fd3 |
container_end_page | 186 |
container_issue | 1 |
container_start_page | 176 |
container_title | Neuropsychopharmacology reports |
container_volume | 44 |
creator | Tanibuchi, Yuko Omiya, Soichiro Usami, Takashi Matsumoto, Toshihiko |
description | Objective
To examine the clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan.
Method
We examined the attributes, ICD‐10 subcategory, and comorbid mental disorders of patients who mainly abuse OTC products and compared the clinical characteristics of single product and multiple products abusers, using the database of the “2022 Nationwide Mental Hospital Survey of Drug‐related Disorders.”
Results
Among the 2468 subjects included in this survey, 273 (11.1%) used OTC products as main drugs. Of these, 209 (78.3%) and 58 (21.7%) were classified into the single product group and the multiple products group, respectively. Six were excluded for unknown ingredients. By comparing these groups, we found that many of the multiple products group consisted of young women who were recently treated for drug problems. Many subjects in the group also had a short treatment period. No differences were observed between the groups regarding the ICD‐10 F1 subcategory, but many subjects in the multiple products group fulfilled the criteria of F6 “disorders of adult personality and behavior.”
Conclusion
OTC products are easily accessible drugs of abuse for young women in Japan. The results of this study indicate the necessity to reconsider the educational approach for preventing drug abuse, which has focused on illicit drugs. The study also indicates that some OTC products, which contain ingredients banned overseas due to their harmful effects, are still sold in Japan and that abusers for those products exist. Measures by the government are considered urgently needed.
We compared single product abusers with multiple product abusers of OTC and conducted a detailed investigation of the clinical characteristics of OTC abusers in Japan. |
doi_str_mv | 10.1002/npr2.12415 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b7c011e39201413d81633d80d3d7ca96</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_b7c011e39201413d81633d80d3d7ca96</doaj_id><sourcerecordid>2955920733</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5415-8d4fbefdcbb47eb2e3b05f225aee2dc19803dcc48c0bab83a0feef22ce8310fd3</originalsourceid><addsrcrecordid>eNp9ks1u1DAQgCMEolXphQdAlrgUpC3-STYJF4QifooqilCRuFn2eLLrVdZO7aRobzwCd96OJ8Fp2qrlwMHjn_n8aWxNlj1l9JhRyl-5PvBjxnNWPMj2eVHmC1aK7w_vrPeywxg3NMHTEPnjbE9UvK55Ifaz301nnQXVEViroGDAYONgIRLfEn-J4c_PX8MaUwQ_upQlR2fnzQtiwrgiSo8RQyTWkT7uYG3VECyQfvJYwOn8k-qVe00av-1VMns3eaN1qw6JcoZsx26wfdoka7rozQjDjfdJ9qhVXcTD6_kg-_b-3XnzcXF69uGkeXu6gCI9e1GZvNXYGtA6L1FzFJoWLeeFQuQGWF1RYQDyCqhWuhKKtogpD1gJRlsjDrKT2Wu82sg-2K0KO-mVlVcHPqykCulBHUpdAmUMRc0py5kwFVuKFKkRpgRVL5PrzezqR71FA-iGoLp70vsZZ9dy5S8lo7XgZVklw9G1IfiLEeMgtzYCdp1y6Mcoec0ZY9WyqBP6_B9048fg0l8lqihSkaUQiXo5UxB8jAHb22oYlVMPyamH5FUPJfjZ3fpv0ZuOSQCbgR-2w91_VPLzl698lv4F7ZXWVw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2955920733</pqid></control><display><type>article</type><title>Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>Wiley-Blackwell Titles (Open access)</source><source>PubMed Central</source><creator>Tanibuchi, Yuko ; Omiya, Soichiro ; Usami, Takashi ; Matsumoto, Toshihiko</creator><creatorcontrib>Tanibuchi, Yuko ; Omiya, Soichiro ; Usami, Takashi ; Matsumoto, Toshihiko</creatorcontrib><description>Objective
To examine the clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan.
Method
We examined the attributes, ICD‐10 subcategory, and comorbid mental disorders of patients who mainly abuse OTC products and compared the clinical characteristics of single product and multiple products abusers, using the database of the “2022 Nationwide Mental Hospital Survey of Drug‐related Disorders.”
Results
Among the 2468 subjects included in this survey, 273 (11.1%) used OTC products as main drugs. Of these, 209 (78.3%) and 58 (21.7%) were classified into the single product group and the multiple products group, respectively. Six were excluded for unknown ingredients. By comparing these groups, we found that many of the multiple products group consisted of young women who were recently treated for drug problems. Many subjects in the group also had a short treatment period. No differences were observed between the groups regarding the ICD‐10 F1 subcategory, but many subjects in the multiple products group fulfilled the criteria of F6 “disorders of adult personality and behavior.”
Conclusion
OTC products are easily accessible drugs of abuse for young women in Japan. The results of this study indicate the necessity to reconsider the educational approach for preventing drug abuse, which has focused on illicit drugs. The study also indicates that some OTC products, which contain ingredients banned overseas due to their harmful effects, are still sold in Japan and that abusers for those products exist. Measures by the government are considered urgently needed.
We compared single product abusers with multiple product abusers of OTC and conducted a detailed investigation of the clinical characteristics of OTC abusers in Japan.</description><identifier>ISSN: 2574-173X</identifier><identifier>EISSN: 2574-173X</identifier><identifier>DOI: 10.1002/npr2.12415</identifier><identifier>PMID: 38299253</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>addiction ; Adult ; Antipsychotics ; Benzodiazepines ; clinical characteristics ; Cold remedies ; Drug abuse ; Drug crimes ; drug dependence ; Drug stores ; Drug Users ; Emergency medical care ; Female ; Hospitals ; Humans ; Japan ; Medical practices ; Mental disorders ; Nonprescription drugs ; Nonprescription Drugs - adverse effects ; Online sales ; Original ; over‐the‐counter drug users ; Prescription drugs ; Psychotropic drugs ; Secondary school students ; Secondary schools ; Self-medication ; Surveys and Questionnaires ; Trends</subject><ispartof>Neuropsychopharmacology reports, 2024-03, Vol.44 (1), p.176-186</ispartof><rights>2024 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.</rights><rights>2024 The Authors. Neuropsychopharmacology Reports published by John Wiley & Sons Australia, Ltd on behalf of The Japanese Society of Neuropsychopharmacology.</rights><rights>2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c5415-8d4fbefdcbb47eb2e3b05f225aee2dc19803dcc48c0bab83a0feef22ce8310fd3</cites><orcidid>0000-0002-1690-6793 ; 0000-0003-2286-8663</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2955920733/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2955920733?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,11562,25753,27924,27925,37012,37013,44590,46052,46476,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38299253$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tanibuchi, Yuko</creatorcontrib><creatorcontrib>Omiya, Soichiro</creatorcontrib><creatorcontrib>Usami, Takashi</creatorcontrib><creatorcontrib>Matsumoto, Toshihiko</creatorcontrib><title>Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers</title><title>Neuropsychopharmacology reports</title><addtitle>Neuropsychopharmacol Rep</addtitle><description>Objective
To examine the clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan.
Method
We examined the attributes, ICD‐10 subcategory, and comorbid mental disorders of patients who mainly abuse OTC products and compared the clinical characteristics of single product and multiple products abusers, using the database of the “2022 Nationwide Mental Hospital Survey of Drug‐related Disorders.”
Results
Among the 2468 subjects included in this survey, 273 (11.1%) used OTC products as main drugs. Of these, 209 (78.3%) and 58 (21.7%) were classified into the single product group and the multiple products group, respectively. Six were excluded for unknown ingredients. By comparing these groups, we found that many of the multiple products group consisted of young women who were recently treated for drug problems. Many subjects in the group also had a short treatment period. No differences were observed between the groups regarding the ICD‐10 F1 subcategory, but many subjects in the multiple products group fulfilled the criteria of F6 “disorders of adult personality and behavior.”
Conclusion
OTC products are easily accessible drugs of abuse for young women in Japan. The results of this study indicate the necessity to reconsider the educational approach for preventing drug abuse, which has focused on illicit drugs. The study also indicates that some OTC products, which contain ingredients banned overseas due to their harmful effects, are still sold in Japan and that abusers for those products exist. Measures by the government are considered urgently needed.
We compared single product abusers with multiple product abusers of OTC and conducted a detailed investigation of the clinical characteristics of OTC abusers in Japan.</description><subject>addiction</subject><subject>Adult</subject><subject>Antipsychotics</subject><subject>Benzodiazepines</subject><subject>clinical characteristics</subject><subject>Cold remedies</subject><subject>Drug abuse</subject><subject>Drug crimes</subject><subject>drug dependence</subject><subject>Drug stores</subject><subject>Drug Users</subject><subject>Emergency medical care</subject><subject>Female</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Japan</subject><subject>Medical practices</subject><subject>Mental disorders</subject><subject>Nonprescription drugs</subject><subject>Nonprescription Drugs - adverse effects</subject><subject>Online sales</subject><subject>Original</subject><subject>over‐the‐counter drug users</subject><subject>Prescription drugs</subject><subject>Psychotropic drugs</subject><subject>Secondary school students</subject><subject>Secondary schools</subject><subject>Self-medication</subject><subject>Surveys and Questionnaires</subject><subject>Trends</subject><issn>2574-173X</issn><issn>2574-173X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9ks1u1DAQgCMEolXphQdAlrgUpC3-STYJF4QifooqilCRuFn2eLLrVdZO7aRobzwCd96OJ8Fp2qrlwMHjn_n8aWxNlj1l9JhRyl-5PvBjxnNWPMj2eVHmC1aK7w_vrPeywxg3NMHTEPnjbE9UvK55Ifaz301nnQXVEViroGDAYONgIRLfEn-J4c_PX8MaUwQ_upQlR2fnzQtiwrgiSo8RQyTWkT7uYG3VECyQfvJYwOn8k-qVe00av-1VMns3eaN1qw6JcoZsx26wfdoka7rozQjDjfdJ9qhVXcTD6_kg-_b-3XnzcXF69uGkeXu6gCI9e1GZvNXYGtA6L1FzFJoWLeeFQuQGWF1RYQDyCqhWuhKKtogpD1gJRlsjDrKT2Wu82sg-2K0KO-mVlVcHPqykCulBHUpdAmUMRc0py5kwFVuKFKkRpgRVL5PrzezqR71FA-iGoLp70vsZZ9dy5S8lo7XgZVklw9G1IfiLEeMgtzYCdp1y6Mcoec0ZY9WyqBP6_B9048fg0l8lqihSkaUQiXo5UxB8jAHb22oYlVMPyamH5FUPJfjZ3fpv0ZuOSQCbgR-2w91_VPLzl698lv4F7ZXWVw</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Tanibuchi, Yuko</creator><creator>Omiya, Soichiro</creator><creator>Usami, Takashi</creator><creator>Matsumoto, Toshihiko</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><general>Wiley</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-1690-6793</orcidid><orcidid>https://orcid.org/0000-0003-2286-8663</orcidid></search><sort><creationdate>202403</creationdate><title>Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers</title><author>Tanibuchi, Yuko ; Omiya, Soichiro ; Usami, Takashi ; Matsumoto, Toshihiko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5415-8d4fbefdcbb47eb2e3b05f225aee2dc19803dcc48c0bab83a0feef22ce8310fd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>addiction</topic><topic>Adult</topic><topic>Antipsychotics</topic><topic>Benzodiazepines</topic><topic>clinical characteristics</topic><topic>Cold remedies</topic><topic>Drug abuse</topic><topic>Drug crimes</topic><topic>drug dependence</topic><topic>Drug stores</topic><topic>Drug Users</topic><topic>Emergency medical care</topic><topic>Female</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Japan</topic><topic>Medical practices</topic><topic>Mental disorders</topic><topic>Nonprescription drugs</topic><topic>Nonprescription Drugs - adverse effects</topic><topic>Online sales</topic><topic>Original</topic><topic>over‐the‐counter drug users</topic><topic>Prescription drugs</topic><topic>Psychotropic drugs</topic><topic>Secondary school students</topic><topic>Secondary schools</topic><topic>Self-medication</topic><topic>Surveys and Questionnaires</topic><topic>Trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tanibuchi, Yuko</creatorcontrib><creatorcontrib>Omiya, Soichiro</creatorcontrib><creatorcontrib>Usami, Takashi</creatorcontrib><creatorcontrib>Matsumoto, Toshihiko</creatorcontrib><collection>Wiley-Blackwell Titles (Open access)</collection><collection>Wiley Free Archive</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Neuropsychopharmacology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanibuchi, Yuko</au><au>Omiya, Soichiro</au><au>Usami, Takashi</au><au>Matsumoto, Toshihiko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers</atitle><jtitle>Neuropsychopharmacology reports</jtitle><addtitle>Neuropsychopharmacol Rep</addtitle><date>2024-03</date><risdate>2024</risdate><volume>44</volume><issue>1</issue><spage>176</spage><epage>186</epage><pages>176-186</pages><issn>2574-173X</issn><eissn>2574-173X</eissn><abstract>Objective
To examine the clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan.
Method
We examined the attributes, ICD‐10 subcategory, and comorbid mental disorders of patients who mainly abuse OTC products and compared the clinical characteristics of single product and multiple products abusers, using the database of the “2022 Nationwide Mental Hospital Survey of Drug‐related Disorders.”
Results
Among the 2468 subjects included in this survey, 273 (11.1%) used OTC products as main drugs. Of these, 209 (78.3%) and 58 (21.7%) were classified into the single product group and the multiple products group, respectively. Six were excluded for unknown ingredients. By comparing these groups, we found that many of the multiple products group consisted of young women who were recently treated for drug problems. Many subjects in the group also had a short treatment period. No differences were observed between the groups regarding the ICD‐10 F1 subcategory, but many subjects in the multiple products group fulfilled the criteria of F6 “disorders of adult personality and behavior.”
Conclusion
OTC products are easily accessible drugs of abuse for young women in Japan. The results of this study indicate the necessity to reconsider the educational approach for preventing drug abuse, which has focused on illicit drugs. The study also indicates that some OTC products, which contain ingredients banned overseas due to their harmful effects, are still sold in Japan and that abusers for those products exist. Measures by the government are considered urgently needed.
We compared single product abusers with multiple product abusers of OTC and conducted a detailed investigation of the clinical characteristics of OTC abusers in Japan.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>38299253</pmid><doi>10.1002/npr2.12415</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-1690-6793</orcidid><orcidid>https://orcid.org/0000-0003-2286-8663</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2574-173X |
ispartof | Neuropsychopharmacology reports, 2024-03, Vol.44 (1), p.176-186 |
issn | 2574-173X 2574-173X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_b7c011e39201413d81633d80d3d7ca96 |
source | Publicly Available Content Database (Proquest) (PQ_SDU_P3); Wiley-Blackwell Titles (Open access); PubMed Central |
subjects | addiction Adult Antipsychotics Benzodiazepines clinical characteristics Cold remedies Drug abuse Drug crimes drug dependence Drug stores Drug Users Emergency medical care Female Hospitals Humans Japan Medical practices Mental disorders Nonprescription drugs Nonprescription Drugs - adverse effects Online sales Original over‐the‐counter drug users Prescription drugs Psychotropic drugs Secondary school students Secondary schools Self-medication Surveys and Questionnaires Trends |
title | Clinical characteristics of over‐the‐counter (OTC) drug abusers in psychiatric practice in Japan: Comparison of single and multiple OTC product abusers |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T23%3A55%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20characteristics%20of%20over%E2%80%90the%E2%80%90counter%20(OTC)%20drug%20abusers%20in%20psychiatric%20practice%20in%20Japan:%20Comparison%20of%20single%20and%20multiple%20OTC%20product%20abusers&rft.jtitle=Neuropsychopharmacology%20reports&rft.au=Tanibuchi,%20Yuko&rft.date=2024-03&rft.volume=44&rft.issue=1&rft.spage=176&rft.epage=186&rft.pages=176-186&rft.issn=2574-173X&rft.eissn=2574-173X&rft_id=info:doi/10.1002/npr2.12415&rft_dat=%3Cproquest_doaj_%3E2955920733%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5415-8d4fbefdcbb47eb2e3b05f225aee2dc19803dcc48c0bab83a0feef22ce8310fd3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2955920733&rft_id=info:pmid/38299253&rfr_iscdi=true |